Findlay J M, Grace M G, Weir B K
Division of Neurosurgery, University of Alberta, Edmonton, Canada.
Neurosurgery. 1993 Jun;32(6):941-7; discussion 947. doi: 10.1227/00006123-199306000-00010.
The patients with intraventricular hemorrhage (IVH) were treated with recombinant tissue plasminogen activator (rt-PA) injected directly into the lateral ventricles, followed by ventricular drainage. All had a decreased level of consciousness before treatment (Glasgow Coma Scale score 10 +/- 3.4). A total dose between 2 and 12 mg of rt-PA (6.4 +/- 3.3) was administered. For eight patients with aneurysmal IVH, treatment with rt-PA began with two patients the same day as the aneurysm clipping, and the day after with six patients. For a patient with an excision of a ruptured arteriovenous malformation and a patient with IVH resulting from a lateral ventricular catheterization during posterior fossa tumor surgery, treatment with rt-PA started 24 hours after surgery. After an injection of rt-PA, the ventricular drain was closed for 1 hour, followed by alternate-hourly drainage and intracranial pressure (ICP) monitoring. Five patients received a second injection of rt-PA on the second postoperative day, and one patient received a third dose on the third day. Among the eight patients given rt-PA the day after surgery, the volume of external cerebrospinal fluid (CSF) drainage for 24 +/- 8 hours before treatment was 61 +/- 57 ml, and the mean ICP was 22 +/- 5 mm Hg during this same time. Younger age and poorer neurological condition correlated with higher ICP before treatment.(ABSTRACT TRUNCATED AT 250 WORDS)
脑室内出血(IVH)患者接受重组组织型纤溶酶原激活剂(rt-PA)直接注入侧脑室治疗,随后进行脑室引流。所有患者治疗前意识水平均下降(格拉斯哥昏迷量表评分为10±3.4)。rt-PA的总剂量为2至12毫克(6.4±3.3)。对于8例动脉瘤性IVH患者,2例在动脉瘤夹闭当天开始用rt-PA治疗,6例在次日开始治疗。对于1例破裂动静脉畸形切除术患者和1例后颅窝肿瘤手术期间因侧脑室置管导致IVH的患者,术后24小时开始用rt-PA治疗。注射rt-PA后,脑室引流管关闭1小时,随后每小时交替引流并监测颅内压(ICP)。5例患者在术后第二天接受了第二次rt-PA注射,1例患者在第三天接受了第三次注射。在术后第二天接受rt-PA治疗的8例患者中,治疗前24±8小时的外部脑脊液(CSF)引流量为61±57毫升,同一时间平均ICP为22±5毫米汞柱。年龄较小和神经功能较差与治疗前较高的ICP相关。(摘要截短至250字)